Sort
48,018 grants matching “immunotherapy”
Function of Wdfy4 in cross-presentation and immunity
$569,250Kenneth M. Murphy · Washington University · R37 · FY2025 · AI
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$569,184Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$569,160Zihai Li · Ohio State University · R01 · FY2021 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$569,136Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Modulation of CSF1R Signaling to Treat Inflammatory Neuropathies
$569,135Kazim A Sheikh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · NS
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model
$569,047Ryan C Fields · Washington University · R01 · FY2024 · CA
UCLA Tumor Immunology Institutional Traning Grant
$569,019Michael A Teitell · University Of California Los Angeles · T32 · FY2021 · CA
Viscoelasticity and T Cell Production
$568,911David J Mooney · Harvard University · R01 · FY2023 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$568,895Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2023 · CA
SYNTHESIS OF CARBOHYDRATE IMMUNOSTIMULANTS
$568,882Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM
Immunotherapy of low grade lymphoid malignancies
$568,871Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
$568,802William Joseph Murphy · University Of California At Davis · R01 · FY2016 · CA
Tumor and host immune signatures associated with patient outcomes to GD2 chemoimmunotherapy in neuroblastoma
$568,722Kelly C Goldsmith · Emory University · R01 · FY2025 · CA
Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
$568,682Yong Lu · Methodist Hospital Research Institute · R01 · FY2025 · CA
Release of interleukin-1a as a mediator of immune evasion in cancer
$568,538Brian Ruffell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
GENOMIC AND COMMENSAL VARIANTS ASSOCIATED WITH IMMUNOTHERAPY IN CANCER PATIENTS
$568,528University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2017 · Department of the Army
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
$568,505Jarrod Dudakov · Fred Hutchinson Cancer Research Center · R01 · FY2020 · HL
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
$568,505Jarrod Dudakov · Fred Hutchinson Cancer Research Center · R01 · FY2021 · HL
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
$568,505Jarrod Dudakov · Fred Hutchinson Cancer Research Center · R01 · FY2019 · HL
Innate lymphoid cell regulation of the host-microbiota interactions in cancer
$568,491Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.
$568,456Nicole Franziska Steinmetz · University Of California, San Diego · U01 · FY2019 · CA
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
$568,426Christiane Querfeld · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$568,413William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
$568,324Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2022 · AI
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation
$568,219Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2024 · CA